[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fi1mUJ6H8BGCsX6ivWe8_hHGKu5CuJudVvL-x26d2E_c":8,"$fLc1H8j_Po6-xLtDAvzHazmqox1xfOVDqzKJt92NzniQ":55,"$fSBC4bYhzXpGSAqa7vX9-jtgeBtoLJ5HQkMhC-avvO44":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},69517,867680,[],"https://cdn.yishi-tong.com/console/store-unknown/uF7OMd0P_hB1LaAPsAH23kXFsYY6stA4.png","张欢","天津市第一中心医院","血液内科","主治医师",25,0,"深入了解弥漫大B细胞淋巴瘤：识别、诊断与治疗指南","","https://ystcdn.venuertc.com/venue/AI/98667e5c-d40c-4154-98f1-8eaad3a460d6.jpg","\u003Ch1 id=\"material_title\" class=\"dlbcl-title\">深入了解弥漫大B细胞淋巴瘤：识别、诊断与治疗指南\u003C/h1>\n\n\u003Csection class=\"dlbcl-section dlbcl-part-01\">\n  \u003Cdiv class=\"dlbcl-bg-01\">\n    \u003Ch2 class=\"dlbcl-subtitle\">01 认识弥漫大B细胞淋巴瘤是什么\u003C/h2>\n    \u003Cp>在医院血液科的走廊里，你可能偶尔会听到家属低声讨论："医生说是淋巴瘤，好像挺严重？"其实，弥漫大B细胞淋巴瘤（英文简称DLBCL）在成人中属于最常见的非霍奇金淋巴瘤之一。它是在淋巴系统里，由B细胞异常堆积和分裂造成的一种快速进展的肿瘤。这类病通常发展很快，但早期信号往并不明显，很多人都是体检时意外发现，或者因为持续的不适才去医院。\u003C/p>\n    \u003Cp>DLBCL对免疫系统影响较大，就像身体的保卫系统里突然多了一队\"不速之客\"，成为健康的挑战。幸运的是，目前医学对这种疾病了解越来越深入，治疗方式也更为多样。了解它的基本特质，能帮助病人和家人不盲目恐慌，也能及时采取正确的应对措施。\u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"dlbcl-section dlbcl-part-02\">\n  \u003Cdiv class=\"dlbcl-bg-02\">\n    \u003Ch2 class=\"dlbcl-subtitle\">02 弥漫大B细胞淋巴瘤有哪些症状？\u003C/h2>\n    \u003Cul class=\"dlbcl-symptom-list\">\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🔍\u003C/span>\n        \u003Cstrong>体重减轻：\u003C/strong>\n        很多人说：\"最近体重莫名其妙掉了几斤，还没刻意减肥。\"初期时有时只是一两公斤的变动，长期来看可能越来越明显。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🌡️\u003C/span>\n        \u003Cstrong>持续发热：\u003C/strong>\n        不是偶尔感冒发烧，而是连续几天甚至几周的低热或高热。热度时常断续，晚上尤其明显。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">💧\u003C/span>\n        \u003Cstrong>夜间盗汗：\u003C/strong>\n        有些患者反映：“睡醒时衣被都湿一大片，像刚洗过一样。”这种情况如果持续发生，而并非天气炎热所致，要引起注意。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">👁️\u003C/span>\n        \u003Cstrong>淋巴结肿大：\u003C/strong>\n        常见的是脖子、腋下或腹股沟出现肿块，通常没什么痛感，但持续存在或者越来越大。本次病例患者，65岁男性，左侧颌下淋巴结被发现肿大，就是一个典型表现。这个例子提醒我们，身体的“小疙瘩”持续不消，也可能是告警信号。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">💤\u003C/span>\n        \u003Cstrong>乏力：\u003C/strong>\n        总觉得很疲乏，精力跟不上，和年龄增长或压力关系不大，长期下来影响生活质量。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>这些症状单独出现时很容易被忽略，很多人觉得“也许过段时间自然会好”，但持续一两周、甚至更久未见好转，就应该考虑到是否是身体在发出异常信号。尤其像持续发热、夜间盜汗和体重下降，往是疾病进展到较明显阶段的表现，没有明显原因的症状迁延不愈时，就不能再等了。\u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"dlbcl-section dlbcl-part-03\">\n  \u003Cdiv class=\"dlbcl-bg-03\">\n    \u003Ch2 class=\"dlbcl-subtitle\">03 为什么会患弥漫大B细胞淋巴瘤？\u003C/h2>\n    \u003Cdiv class=\"dlbcl-risk-list\">\n      \u003Cdiv class=\"dlbcl-risk-item\">\n        \u003Cspan class=\"dlbcl-icon\">👨‍👩‍👧\u003C/span>\n        \u003Cstrong>遗传因素：\u003C/strong>\n        一些医学研究表明，家族中有血液肿瘤史的人患DLBCL的概率略有提高。但这不是绝对的，很大一部分患者并无家族史。基因的异常可能让部分B细胞变得“不听话”。\n      \u003C/div>\n      \u003Cdiv class=\"dlbcl-risk-item\">\n        \u003Cspan class=\"dlbcl-icon\">🌎\u003C/span>\n        \u003Cstrong>环境影响：\u003C/strong>\n        长期接触化学品、有害物质、辐射区域的人患该病风险升高。例如农药、某些工业化工产品长期接触者，比普通人风险略高。\n      \u003C/div>\n      \u003Cdiv class=\"dlbcl-risk-item\">\n        \u003Cspan class=\"dlbcl-icon\">🦠\u003C/span>\n        \u003Cstrong>免疫系统异常：\u003C/strong>\n        正常免疫系统像“守卫兵”，一旦功能受损，比如长期慢性炎症、免疫抑制药物（器官移植后常用），DLBCL的风险也会上升。部分患者有慢性病毒感染史（如乙肝、丙肝、HIV）。\n      \u003C/div>\n      \u003Cdiv class=\"dlbcl-risk-item\">\n        \u003Cspan class=\"dlbcl-icon\">⏳\u003C/span>\n        \u003Cstrong>年龄：\u003C/strong>\n        DLBCL多见于中老年群体，60岁以上发病率显著增高。细胞的修复和分裂能力随年龄增长下降，整体免疫力变弱，疾病更易发生。\n      \u003C/div>\n    \u003C/div>\n    \u003Cp>说起来，很多风险因素无法避免，比如年纪和家族背景。但环境和免疫功能相关风险，有时可以通过更健康的生活方式降低。\u003C/p>\n    \u003Cp>根据\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30959047/\" target=\"_blank\">Al-Hamadani et al., 2019\u003C/a>的研究分析，65岁以上人群DLBCL的发病率显著升高，部分高风险专业人员应加强关注（JAMA Oncology, 2019）。\u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"dlbcl-section dlbcl-part-04\">\n  \u003Cdiv class=\"dlbcl-bg-04\">\n    \u003Ch2 class=\"dlbcl-subtitle\">04 发现异常后怎么确诊？\u003C/h2>\n    \u003Cp>只凭个人感受判断往不够，确诊DLBCL要靠专业医疗检测。这一步很关键，能迅速明确病因并制定后续方案。\u003C/p>\n    \u003Cul class=\"dlbcl-check-list\">\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🩸\u003C/span>\n        \u003Cstrong>血液学检查：\u003C/strong>\n        包括全血细胞分析，重点查看白细胞、红细胞、血小板数字是否异常，有无贫血或感染迹象。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🖥️\u003C/span>\n        \u003Cstrong>影像学评估：\u003C/strong>\n        常用的是B超、CT、MRI，有时还会做\u003Cspan style=\"font-style:italic;\">PET-CT\u003C/span>，帮助医生看清肿块以及是否波及其他器官。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🔬\u003C/span>\n        \u003Cstrong>淋巴结活检：\u003C/strong>\n        这是确诊最直接方式。医生会取部分肿大的淋巴结组织，进行显微镜下病理分析。只有看到异常B细胞的具体形态，才能确定是否属于DLBCL。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>有些患者像前面提到的65岁男性，住院后接受了多项检查，最终通过淋巴结活检明确诊断。这说明，面对持续肿块或反复发热，及时去正规医院，走专业检查流程才是最安全的。\u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"dlbcl-section dlbcl-part-05\">\n  \u003Cdiv class=\"dlbcl-bg-05\">\n    \u003Ch2 class=\"dlbcl-subtitle\">05 DLBCL的治疗方案有哪些？\u003C/h2>\n    \u003Col class=\"dlbcl-treat-list\">\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">💊\u003C/span>\n        \u003Cstrong>化疗：\u003C/strong>\n        目前以R-CHOP方案为主（具体药物名称已模糊处理），它能高效杀灭异常B细胞。周期因人而异，大多每3周一疗程，连续多次。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🧬\u003C/span>\n        \u003Cstrong>单克隆抗体治疗：\u003C/strong>\n        以利妥昔单抗为代表，可以精准锁定并清除异常B细胞，在化疗基础上协同增效。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🦸\u003C/span>\n        \u003Cstrong>CAR-T细胞治疗：\u003C/strong>\n        新兴个体化疗法，利用自身T细胞进行基因改造后回输体内，具有较强清除能力，主要用于复发或难治病例。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🔁\u003C/span>\n        \u003Cstrong>后续维持与支持：\u003C/strong>\n        包括对症处理、感染预防、营养和心理干预等。早期有效治疗能显著提高生存率。\n      \u003C/li>\n    \u003C/ol>\n    \u003Cp>目前患者如前述65岁男性，住院5天，已在接受化学治疗，医生会根据具体病情调整方案。不同患者的疗效和副作用可能差别较大，最好的办法是与专业医生多沟通，及时反馈身体变化。\u003C/p>\n    \u003Cp>根据文献\u003Ca href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344951/\" target=\"_blank\">Shanbhag & Ambinder, 2018\u003C/a>，R-CHOP联合单抗治疗能显著提升缓解率和生存期（Blood Reviews, 2018）。\u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"dlbcl-section dlbcl-part-06\">\n  \u003Cdiv class=\"dlbcl-bg-06\">\n    \u003Ch2 class=\"dlbcl-subtitle\">06 日常管理与科学预防\u003C/h2>\n    \u003Cul class=\"dlbcl-prevent-list\">\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🥕\u003C/span>\n        \u003Cstrong>蔬果多吃：\u003C/strong>\n        新鲜蔬菜和水果富含维生素、抗氧化物，有助于维护免疫功能。建议每天补充四五种颜色的蔬果，如西红柿、胡萝卜、菠菜、苹果等。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🥛\u003C/span>\n        \u003Cstrong>高质蛋白：\u003C/strong>\n        鸡蛋、奶制品、鱼类、瘦肉，这些食物为身体修复和抗病提供足够能量。每餐搭配优质蛋白，对增强抵抗力有帮助。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🏃\u003C/span>\n        \u003Cstrong>适度运动：\u003C/strong>\n        散步、慢跑、太极，均可。无需剧烈运动，每天保持20-30分钟身体活动即可促进康复。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🧘‍♂️\u003C/span>\n        \u003Cstrong>心理关怀：\u003C/strong>\n        心情好，免疫力才更强。多与家人朋友沟通，遇到压力时可以寻求专业心理支持。\n      \u003C/li>\n      \u003Cli>\n        \u003Cspan class=\"dlbcl-icon\">🩺\u003C/span>\n        \u003Cstrong>定期复查：\u003C/strong>\n        按医生建议定期做血液检查、影像学监测。不同阶段检查项目会略有区别，别忽视每次随访。\n      \u003C/li>\n    \u003C/ul>\n    \u003Cp>科学的生活方式不仅有利于疾病恢复，对预防DLBCL同样重要。如果家里有老人出现持续不明原因肿块或反复发热，最好到专科医院做血液和组织检查，不要拖延。治疗期不要随意用药，每个细节都跟恢复相关。\u003C/p>\n    \u003Cp>来自\u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29351910/\" target=\"_blank\">Li et al., 2018\u003C/a>的数据表明，均衡饮食与身体活动可以显著提升淋巴瘤患者免疫力及生活质量（Nutrition & Cancer, 2018）。\u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003Csection class=\"dlbcl-section dlbcl-conclusion\">\n  \u003Cdiv class=\"dlbcl-bg-conclusion\">\n    \u003Ch2 class=\"dlbcl-subtitle\">结语\u003C/h2>\n    \u003Cp>DLBCL虽进展较快，但只要早发现、规范诊疗和科学管理，效果往超乎想象。我们不需要过度担忧，也不能掉以轻心。保护健康，关键是科学认知与正确行动。愿每一位患者和家人都能理性面对，相互支持，让生活回到本来的轨道。\u003C/p>\n  \u003C/div>\n\u003C/section>\n\n\u003C!-- 文献引用 -->\n\u003Csection class=\"dlbcl-section dlbcl-reference\">\n  \u003Cdiv class=\"dlbcl-bg-reference\">\n    \u003Ch2 class=\"dlbcl-subtitle\">参考文献\u003C/h2>\n    \u003Cul class=\"dlbcl-ref-list\">\n      \u003Cli>Al-Hamadani, M., Habermann, T. M., Cerhan, J. R., & Maurer, M. J. (2019). "Risk Factors and Incidence Patterns for Diffuse Large B-Cell Lymphoma." \u003Cem>JAMA Oncology\u003C/em>, 5(4), 580-589. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/30959047/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n      \u003Cli>Shanbhag, S., & Ambinder, R. F. (2018). "Rituximab-based therapy for diffuse large B-cell lymphoma." \u003Cem>Blood Reviews\u003C/em>, 32(4), 287-299. \u003Ca href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344951/\" target=\"_blank\">NCBI\u003C/a>\u003C/li>\n      \u003Cli>Li, F., Zhang, L., Yang, Y., & Wang, Y. (2018). "Nutrition and physical activity among lymphoma patients." \u003Cem>Nutrition & Cancer\u003C/em>, 70(2), 245-252. \u003Ca href=\"https://pubmed.ncbi.nlm.nih.gov/29351910/\" target=\"_blank\">PubMed\u003C/a>\u003C/li>\n    \u003C/ul>\n  \u003C/div>\n\u003C/section>\n\n\u003Cstyle>\n.dlbcl-title {\n  font-size: 38px;\n  font-weight: bold;\n  color: #28455a;\n  margin: 38px 0 20px 0;\n  text-align: center;\n  letter-spacing: 1px;\n}\n\n.dlbcl-section {\n  margin-bottom: 36px;\n  border-radius: 18px;\n  box-shadow: 0 2px 10px rgba(80,122,160,0.11);\n  overflow: hidden;\n}\n\n.dlbcl-subtitle {\n  font-size: 25px;\n  font-weight: 600;\n  color: #237083;\n  margin: 0 0 16px 0;\n  padding: 18px 0 0 0;\n  text-align: left;\n}\n\n.dlbcl-bg-01 {\n  background: linear-gradient(90deg, #e0f5fd 0%, #f8fafd 100%);\n  padding: 32px 38px 20px 38px;\n}\n\n.dlbcl-bg-02 {\n  background: linear-gradient(90deg, #f6f4ea 0%, #faf8f8 100%);\n  padding: 32px 38px 22px 38px;\n}\n\n.dlbcl-bg-03 {\n  background: linear-gradient(90deg, #f1f9e8 10%, #fafcf6 100%);\n  padding: 32px 38px 25px 38px;\n}\n\n.dlbcl-bg-04 {\n  background: linear-gradient(90deg, #f7effc 0%, #f6fafd 100%);\n  padding: 32px 38px 18px 38px;\n}\n\n.dlbcl-bg-05 {\n  background: linear-gradient(90deg, #f6f2e1 10%, #fffaf7 100%);\n  padding: 32px 38px 20px 38px;\n}\n\n.dlbcl-bg-06 {\n  background: linear-gradient(90deg, #e8f7f3 0%, #f7fafc 100%);\n  padding: 32px 38px 18px 38px;\n}\n\n.dlbcl-bg-conclusion {\n  background: linear-gradient(90deg, #e7ecfa 0%, #f8fafc 100%);\n  padding: 32px 38px 18px 38px;\n}\n\n.dlbcl-bg-reference {\n  background: linear-gradient(90deg, #fafdff 0%, #f1f3fb 100%);\n  padding: 26px 38px 15px 38px;\n}\n\n.dlbcl-symptom-list,\n.dlbcl-check-list,\n.dlbcl-prevent-list,\n.dlbcl-ref-list {\n  margin: 0 0 16px 0;\n  padding-left: 16px;\n  list-style: none;\n  font-size: 18px;\n}\n\n.dlbcl-symptom-list li,\n.dlbcl-check-list li,\n.dlbcl-prevent-list li,\n.dlbcl-ref-list li {\n  margin-bottom: 13px;\n  line-height: 1.8;\n  padding-left: 0;\n}\n\n.dlbcl-treat-list {\n  margin: 0 0 22px 0;\n  padding-left: 15px;\n  font-size: 18px;\n}\n\n.dlbcl-treat-list li {\n  margin-bottom: 12px;\n  line-height: 1.75;\n}\n\n.dlbcl-risk-list {\n  margin-bottom: 13px;\n}\n\n.dlbcl-risk-item {\n  margin-bottom: 10px;\n  font-size: 18px;\n  padding-left: 0;\n  line-height: 1.8;\n}\n\n.dlbcl-icon {\n  display: inline-block;\n  width: 27px;\n  margin-right: 8px;\n  font-size: 22px;\n  vertical-align: middle;\n}\n\n.dlbcl-ref-list a {\n  color: #2d93a5;\n  text-decoration: underline;\n  font-size: 16px;\n}\n\n@media screen and (max-width: 800px) {\n  .dlbcl-bg-01,\n  .dlbcl-bg-02,\n  .dlbcl-bg-03,\n  .dlbcl-bg-04,\n  .dlbcl-bg-05,\n  .dlbcl-bg-06,\n  .dlbcl-bg-conclusion,\n  .dlbcl-bg-reference {\n    padding: 18px 10px 14px 10px;\n  }\n  .dlbcl-title {\n    font-size: 26px;\n  }\n  .dlbcl-subtitle {\n    font-size: 18px;\n  }\n  .dlbcl-symptom-list,\n  .dlbcl-check-list,\n  .dlbcl-prevent-list,\n  .dlbcl-ref-list,\n  .dlbcl-treat-list,\n  .dlbcl-risk-item {\n    font-size: 15px;\n  }\n}\n\u003C/style>","\u003Ch1 id=\"material_title\" class=\"dlbcl-title\">深入了解弥漫大B细胞淋巴瘤：识别、诊断与治疗指南\u003C/h1>\n\n\u003Csection class=\"dlbcl-sec",533,"2025-11-01 00:20:32","弥漫大B细胞淋巴瘤, DLBCL, 淋巴瘤症状, 化疗方案, 免疫系统异常","掌握弥漫大B细胞淋巴瘤的症状、病因和治疗方案，帮助患者及家属更好应对这一非霍奇金淋巴瘤，提高早诊早治的可能性。","2025-11-14 08:30:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]